VANGUARD GROUP INC - BIND THERAPEUTICS INC ownership

BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 37 filers reported holding BIND THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BIND THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$1,091,000
-3.9%
495,864
+0.1%
0.00%
Q4 2015$1,135,000
-99.4%
495,564
-91.0%
0.00%
-100.0%
Q3 2015$177,885,000
+6942.2%
5,488,396
+1114.3%
0.01%
Q2 2015$2,526,000
+7.6%
451,982
+5.7%
0.00%
Q1 2015$2,348,000
+137.2%
427,702
+133.4%
0.00%
Q4 2014$990,000
-35.5%
183,278
+2.5%
0.00%
Q3 2014$1,536,000
-13.5%
178,850
+32.7%
0.00%
Q2 2014$1,776,000
+5.0%
134,785
-4.6%
0.00%
Q1 2014$1,691,000
+83.8%
141,342
+131.9%
0.00%
Q4 2013$920,00060,9590.00%
Other shareholders
BIND THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 2,018,253$9,001,0006.13%
FNY Managed Accounts LLC 30,000$133,800,0000.37%
Rhenman & Partners Asset Management AB 133,535$596,0000.10%
THOMPSON DAVIS & CO., INC. 4,500$20,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 26,000$116,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 83,593$373,0000.01%
VANGUARD GROUP INC 5,488,396$177,885,0000.01%
Alyeska Investment Group, L.P. 114,786$512,0000.01%
Renaissance Technologies 269,300$1,201,0000.00%
PRINCIPAL FINANCIAL GROUP INC 324,900$1,449,0000.00%
View complete list of BIND THERAPEUTICS INC shareholders